Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapy

Cancer

Volumn 120, Issue 1, 2014, Pages 126-133

  Sethi, Roshan V ^a   Shih, Helen A ^b   Yeap, Beow Y ^b   Mouw, Kent W ^b   Petersen, Robert ^c   Kim, David Y ^d   Munzenrider, John E ^b   Grabowski, Eric ^b   Rodriguez Galindo, Carlos ^c   Yock, Torunn I ^b   Tarbell, Nancy J ^b   Marcus, Karen J ^c   Mukai, Shizuo ^d   MacDonald, Shannon M ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

proton; retinoblastoma; second cancer; second malignancy

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER RISK; CANCER SURVIVOR; CHILD; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLIOBLASTOMA; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MAXILLA TUMOR; MAXILLARY SARCOMA; NEWBORN; ORBIT SARCOMA; ORBIT TUMOR; OSTEOSARCOMA; PHOTON THERAPY; PRIORITY JOURNAL; PROTON THERAPY; RADIATION INDUCED NEOPLASM; RETINOBLASTOMA; SARCOMA; SECOND CANCER;

PROTON; RETINOBLASTOMA; SECOND CANCER; SECOND MALIGNANCY;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; PROTON THERAPY; PROTONS; RETINOBLASTOMA; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84890799421     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28387     Document Type: Article

References (29)

1. Ries LAG, Smith MA, Gurney JG, et al, eds. Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995. Bethesda, MD: National Cancer Institute, National Institutes of Health; 1999.
2. Kleinerman RA, Yu CL, Little MP, et al. Variation of second cancer risk by family history of retinoblastoma among long-term survivors. J Clin Oncol. 2012; 30: 950-957.
3. Knudsen ES, Wang JY,. Targeting the RB-pathway in cancer therapy. Clin Cancer Res. 2010; 16: 1094-1099.
4. Chantada G, Fandino A, Davila MT, et al. Results of a prospective study for the treatment of retinoblastoma. Cancer. 2004; 100: 834-842. (Pubitemid 38176864)
5. Eng C, Li FP, Abramson DH, et al. Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst. 1993; 85: 1121-1128. (Pubitemid 23212278)
6. Yu CL, Tucker MA, Abramson DH, et al. Cause-specific mortality in long-term survivors of retinoblastoma. J Natl Cancer Inst. 2009; 101: 581-591.
7. Draper GJ, Sanders BM, Kingston JE,. Second primary neoplasms in patients with retinoblastoma. Br J Cancer. 1986; 53: 661-671. (Pubitemid 16114627)
8. Fletcher O, Easton D, Anderson K, Gilham C, Jay M, Peto J,. Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst. 2004; 96: 357-363. (Pubitemid 38401013)
9. Frobisher C, Gurung PM, Leiper A, et al. Risk of bladder tumours after childhood cancer: the British Childhood Cancer Survivor Study. BJU Int. 2010; 106: 1060-1069.
10. Imhof SM, Moll AC, Hofman P, Mourits MP, Schipper J, Tan KE,. Second primary tumours in hereditary- and nonhereditary retinoblastoma patients treated with megavoltage external beam irradiation. Doc Ophthalmol. 1997; 93: 337-344. (Pubitemid 28261028)
11. Kleinerman RA, Tucker MA, Tarone RE, et al. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol. 2005; 23: 2272-2279. (Pubitemid 46218720)
12. Li FP, Abramson DH, Tarone RE, Kleinerman RA, Fraumeni JF Jr, Boice JD Jr,. Hereditary retinoblastoma, lipoma, and second primary cancers. J Natl Cancer Inst. 1997; 89: 83-84. (Pubitemid 26428082)
13. Marees T, Moll AC, Imhof SM, de Boer MR, Ringens PJ, van Leeuwen FE,. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up. J Natl Cancer Inst. 2008; 100: 1771-1779.
14. Mohney BG, Robertson DM, Schomberg PJ, Hodge DO,. Second nonocular tumors in survivors of heritable retinoblastoma and prior radiation therapy. Am J Ophthalmol. 1998; 126: 269-277. (Pubitemid 28397100)
15. Moll AC, Imhof SM, Bouter LM, et al. Second primary tumors in patients with hereditary retinoblastoma: a register-based follow-up study, 1945-1994. Int J Cancer. 1996; 67: 515-519. (Pubitemid 26274108)
16. Tucker MA, D'Angio GJ, Boice JD Jr, et al. Bone sarcomas linked to radiotherapy and chemotherapy in children. N Engl J Med. 1987; 317: 588-593. (Pubitemid 17126781)
17. Wong FL, Boice JD Jr, Abramson DH, et al. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA. 1997; 278: 1262-1267.
18. Moll AC, Imhof SM, Schouten-Van Meeteren AY, Kuik DJ, Hofman P, Boers M. Second primary tumors in hereditary retinoblastoma: a register-based study, 1945-1997: is there an age effect on radiation-related risk? Ophthalmology. 2001; 108: 1109-1114. (Pubitemid 32500029)
19. MacCarthy A, Bayne AM, Draper GJ, et al. Non-ocular tumours following retinoblastoma in Great Britain 1951 to 2004. Br J Ophthalmol. 2009; 93: 1159-1162.
20. Turaka K, Shields CL, Meadows AT, Leahey A,. Second malignant neoplasms following chemoreduction with carboplatin, etoposide, and vincristine in 245 patients with intraocular retinoblastoma. Pediatr Blood Cancer. 2012; 59: 121-125.
21. Cassady JR, Sagerman RH, Tretter P, Ellsworth RM,. Radiation therapy in retinoblastoma. An analysis of 230 cases. Radiology. 1969; 93: 405-409.
22. Pradhan DG, Sandridge AL, Mullaney P, et al. Radiation therapy for retinoblastoma: a retrospective review of 120 patients. Int J Radiat Oncol Biol Phys. 1997; 39: 3-13. (Pubitemid 27396276)
23. Schipper J, Tan KE, van Peperzeel HA,. Treatment of retinoblastoma by precision megavoltage radiation therapy. Radiother Oncol. 1985; 3: 117-132. (Pubitemid 15170206)
24. Abramson DH, Beaverson KL, Chang ST, Dunkel IJ, McCormick B,. Outcome following initial external beam radiotherapy in patients with Reese-Ellsworth group Vb retinoblastoma. Arch Ophthalmol. 2004; 122: 1316-1323. (Pubitemid 39180851)
25. Shields CL, Honavar SG, Meadows AT, et al. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation. Am J Ophthalmol. 2002; 133: 657-664. (Pubitemid 34462014)
26. Lee CT, Bilton SD, Famiglietti RM, et al. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques? Int J Radiat Oncol Biol Phys. 2005; 63: 362-372. (Pubitemid 41317152)
27. Krasin MJ, Crawford BT, Zhu Y, et al. Intensity-modulated radiation therapy for children with intraocular retinoblastoma: potential sparing of the bony orbit. Clin Oncol (R Coll Radiol). 2004; 16: 215-222. (Pubitemid 38559692)
28. Chauveinc L, Mosseri V, Quintana E, et al. Osteosarcoma following retinoblastoma: age at onset and latency period. Ophthalmic Genet. 2001; 22: 77-88. (Pubitemid 32881494)
29. Abramson DH,. Retinoblastoma in the 20th century: past success and future challenges the Weisenfeld lecture. Invest Ophthalmol Vis Sci. 2005; 46: 2683-2691.